Genetic Variants as Predictive Markers for Ototoxicity and Nephrotoxicity in Patients with Locally Advanced Head and Neck Cancer Treated with Cisplatin-Containing Chemoradiotherapy (The PRONE Study)

Ototoxicity and nephrotoxicity are potentially irreversible side effects of chemoradiotherapy with cisplatin in locally advanced head and neck cancer (LAHNC) patients. Several predictive genetic variants have been described, but as yet none in LAHNC patients. The aim of this study is to investigate...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cancers (Basel)
Autors principals: Driessen, Chantal M., Ham, Janneke C., te Loo, Maroeska, van Meerten, Esther, van Lamoen, Maurits, Hakobjan, Marina H., Takes, Robert P., van der Graaf, Winette T., Kaanders, Johannes H., Coenen, Marieke J.H., van Herpen, Carla M.
Format: Artigo
Idioma:Inglês
Publicat: MDPI 2019
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6520709/
https://ncbi.nlm.nih.gov/pubmed/30999660
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers11040551
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars